CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 176 enrolled
Drug / intervention
Celsite chemoport implantation +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01733342
NCT01733342Phase 4Completed
CompareCT.gov

Single-center Randomized Trial for Comparison of Performance Between Domestic and Imported Chemoport

Seoul National University Hospital·interventional·Posted Nov 27, 2012·Updated Dec 4, 2013

In Brief

A Phase 4 clinical trial evaluating Celsite chemoport implantation, local anesthesia, and 1 other intervention for Cancer. Completed, enrolled 176 participants across 1 site.

Detailed Summary

To compare the performance of domestic chemoport and imported chemoport

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesSouth Korea
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedNov 27, 2012
Enrollment StartNov 1, 2012
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 13.6 years ago

Interventions

Celsite chemoport implantationdevice

Celsite chemoport implantation was done under local anesthesia, at anterior chest wall, under ultrasound guidance

local anesthesiaprocedure

chemoport implantation will be done under local anesthesia using lidocaine.

Humanport chemoport implantationdevice

Humanport chemoport implantation was done under local anesthesia, at anterior chest wall, under ultrasound guidance